Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial

Detalhes bibliográficos
Autor(a) principal: Araújo, António
Data de Publicação: 2013
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4095
Resumo: Cancer has the potential to induce hypercoagulable states. On the other hand, venous thromboembolism may be the harbinger of an occult cancer, may represent a complication of known malignant disease or complicate hospitalization, surgery or various systemic treatments. The importance of venous thromboembolism in patients with cancer is often underestimated resulting in under-diagnosis, which may lead to significant morbidity and mortality. However, many cancer patients do not receive prophylaxis and suitable treatment for venous thromboembolism. The author make some considerations on this disease by addressing the interest and the objectives of the clinical trial CATCH and use of sodium tinzaparin.
id RCAP_bf1781085ddea86968b489390ce8a6f3
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/4095
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical TrialCancro e Trombose Venosa Profunda: a Propósito do Ensaio Clínico CatchCancer has the potential to induce hypercoagulable states. On the other hand, venous thromboembolism may be the harbinger of an occult cancer, may represent a complication of known malignant disease or complicate hospitalization, surgery or various systemic treatments. The importance of venous thromboembolism in patients with cancer is often underestimated resulting in under-diagnosis, which may lead to significant morbidity and mortality. However, many cancer patients do not receive prophylaxis and suitable treatment for venous thromboembolism. The author make some considerations on this disease by addressing the interest and the objectives of the clinical trial CATCH and use of sodium tinzaparin.O cancro tem o potencial de induzir estados de hipercoagulabilidade. Por outro lado, o tromboembolismo venoso pode ser o prenúncio de um cancro oculto, pode representar uma complicação de uma doença oncológica já conhecida ou complicar uma hospitalização, cirurgia ou os vários tratamentos sistémicos. A importância do tromboembolismo venoso para os doentes com cancro é frequentemente subestimado resultando em subdiagnóstico, o que pode conduzir a morbilidade e mortalidade significativas. No entanto, muitos doentes oncológicos não recebem a profilaxia e o tratamento apropriados para a tromboembolismo venoso. O autor faz algumas considerações sobre esta patologia, abordando o interesse e os objectivos do ensaio clínico CATCH e da utilização da tinzaparina sódica. Palavras-chave: Neoplasias; Trombose Venosa ProfundaOrdem dos Médicos2013-05-31info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4095oai:ojs.www.actamedicaportuguesa.com:article/4095Acta Médica Portuguesa; Vol. 26 No. 2 (2013): March-April; 83-85Acta Médica Portuguesa; Vol. 26 N.º 2 (2013): Março-Abril; 83-851646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4095https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4095/3231Araújo, Antónioinfo:eu-repo/semantics/openAccess2022-12-20T11:03:15Zoai:ojs.www.actamedicaportuguesa.com:article/4095Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:18:41.463319Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial
Cancro e Trombose Venosa Profunda: a Propósito do Ensaio Clínico Catch
title Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial
spellingShingle Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial
Araújo, António
title_short Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial
title_full Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial
title_fullStr Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial
title_full_unstemmed Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial
title_sort Cancer and Deep Venous Thrombosis: the Purpose of the CATCH Clinical Trial
author Araújo, António
author_facet Araújo, António
author_role author
dc.contributor.author.fl_str_mv Araújo, António
description Cancer has the potential to induce hypercoagulable states. On the other hand, venous thromboembolism may be the harbinger of an occult cancer, may represent a complication of known malignant disease or complicate hospitalization, surgery or various systemic treatments. The importance of venous thromboembolism in patients with cancer is often underestimated resulting in under-diagnosis, which may lead to significant morbidity and mortality. However, many cancer patients do not receive prophylaxis and suitable treatment for venous thromboembolism. The author make some considerations on this disease by addressing the interest and the objectives of the clinical trial CATCH and use of sodium tinzaparin.
publishDate 2013
dc.date.none.fl_str_mv 2013-05-31
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4095
oai:ojs.www.actamedicaportuguesa.com:article/4095
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4095
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/4095
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4095
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4095/3231
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 26 No. 2 (2013): March-April; 83-85
Acta Médica Portuguesa; Vol. 26 N.º 2 (2013): Março-Abril; 83-85
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130638421327872